Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Lexicon Pharmaceuticals Inc (NASDAQ:LXRX)

15.60
Delayed Data
As of Dec 09
 +0.11 / +0.71%
Today’s Change
7.65
Today|||52-Week Range
19.62
+17.21%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$1.6B

Company Description

Lexicon Pharmaceuticals, Inc. is a biopharmaceutical company, focuses on the development of breakthrough treatments for human disease. It has multiple programs in clinical development for diabetes, irritable bowel syndrome, carcinoid syndrome and other indications. Lexicon Pharmaceuticals was founded by Brian P. Zambrowicz and Arthur T. Sands on July 7, 1995 and is headquartered in The Woodlands, TX.

Contact Information

Lexicon Pharmaceuticals, Inc.
8800 Technology Forest Place
The Woodlands Texas 77381-1160
P:(281) 863-3000
Investor Relations:

Employees

Shareholders

Other institutional76.41%
Individual stakeholders55.54%
Mutual fund holders28.70%

Top Executives

Lonnel CoatsPresident, Chief Executive Officer & Director
Jeffrey L. WadeCFO, EVP-Corporate & Administrative Affairs
Pablo LapuertaChief Medical Officer & EVP-Clinical Development
Brian T. CrumSecretary, Vice President & General Counsel
Alan J. MainExecutive Vice President-CMC & Supply Operations